Physician profile
Joseph Minick
NPI 1215975925
$3,596.92
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $246 · 2021: $507 · 2022: $896 · 2023: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590 · Education: $12.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.55 |
| Education | $12.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $552.19 | 2021-2023 | |
| Axsome Therapeutics, INC. | $535.44 | 2023 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $528.74 | 2019-2023 | Rexulti |
| Abbvie INC. | $424.37 | 2021-2023 | |
| Alkermes, INC. | $328.93 | 2019-2023 | Lybalvi, Aristada |
| Takeda Pharmaceuticals U.S.A., INC. | $237.25 | 2022-2023 | Trintellix |
| Neurocrine Biosciences, INC. | $214.12 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $167.21 | 2019-2023 | Austedo Xr |
| Vanda Pharmaceuticals INC. | $130.43 | 2022-2023 | Fanapt, Hetlioz |
| Lundbeck LLC | $113.38 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $106.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $90.18 | 2021 | |
| Allergan, INC. | $77.85 | 2020 | |
| Idorsia Pharmaceuticals US INC | $73.44 | 2023 | Quviviq |
| Almatica Pharma LLC | $17.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Minick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.